Search

Your search keyword '"Wei, Shu-Chen"' showing total 514 results

Search Constraints

Start Over You searched for: Author "Wei, Shu-Chen" Remove constraint Author: "Wei, Shu-Chen"
514 results on '"Wei, Shu-Chen"'

Search Results

1. Noninvasive, microbiome-based diagnosis of inflammatory bowel disease

2. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

6. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)

7. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

8. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

10. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses

17. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

18. Nanotechnology for Targeted Inflammatory Bowel Disease Therapy: Challenges and Opportunities.

21. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

22. MODELING THE TRANSITION TO THE FOURTH EPIDEMIOLOGIC STAGE OF INFLAMMATORY BOWEL DISEASE: PREVALENCE EQUILIBRIUM

23. The Global Evolution of Inflammatory Bowel Disease across Four Epidemiologic Stages

24. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

25. Ulcerative colitis

32. Additional file 1 of Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)

33. Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study

39. The pregnancy outcome and drug usage during pregnancy among Taiwanese inflammatory bowel disease patients

41. Perioperative optimization of Crohn's disease

42. Asian Organization for Crohnʼs and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 2: Management

43. Asian Organization for Crohnʼs and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk assessment

46. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses

48. Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease

49. EP1308: 6-THIOGUANINE NUCLEOTIDE LEVELS AND ANTI-TNFα TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A RETROSPECTIVE MULTICENTRE STUDY

Catalog

Books, media, physical & digital resources